Vivici, a biotech venture founded in Dubai, announced that it has received €13.2 million (about $14.4 million) from the European Innovation Council (EIC). The funding is earmarked for scaling its precision‑fermented dairy protein technology, a process that creates milk proteins without the need for traditional animal farming. For the UAE’s fast‑growing agri‑tech ecosystem, the deal signals a shift toward high‑value, low‑impact food production that aligns with national sustainability goals.
The capital injection follows a competitive selection process that pits hundreds of European and global startups against each other. Vivici’s win highlights the growing confidence of international investors in Middle Eastern biotech talent and the region’s supportive regulatory environment. By leveraging the EIC’s network, the company expects to accelerate pilot‑scale production, secure additional strategic partnerships, and fast‑track entry into key markets across the Gulf Cooperation Council (GCC) and Europe.
Precision Fermentation: A Game Changer for Dairy Alternatives
Precision fermentation uses microorganisms engineered to produce specific proteins that are chemically identical to those found in cow’s milk. Unlike plant‑based alternatives, the resulting product delivers the same functional properties, such as meltability and foaming, required by chefs and manufacturers. Vivici’s proprietary yeast platform can generate whey and casein at a fraction of the water, land, and greenhouse‑gas footprint of conventional dairy.
The startup’s technology also offers flexibility in flavor and nutritional profile. By adjusting the microbial strains, Vivici can tailor protein blends for specialty applications, ranging from high‑protein sports drinks to infant formula. This adaptability gives the company a competitive edge in a market where consumer expectations are rapidly evolving toward clean‑label, nutritionally robust options.
Market Impact and Growth Strategy
The GCC region is witnessing a surge in demand for sustainable food solutions, driven by rising disposable incomes and heightened awareness of climate impact. Governments across the Gulf have launched initiatives to diversify food sources and reduce reliance on imports. Vivici’s expanded capacity positions it to become a regional supplier of premium dairy proteins, potentially lowering import bills and supporting local food security objectives.
With the new funding, Vivici plans to:
- Scale up its fermentation facility to a 10,000‑liter capacity, enabling commercial‑grade output within 18 months.
- Establish a supply chain hub in Abu Dhabi’s Masdar City, leveraging the free‑zone’s renewable‑energy infrastructure.
- Forge joint‑development agreements with major dairy processors in Saudi Arabia and Qatar, integrating fermented proteins into existing product lines.
These steps are designed to capture a share of the GCC’s projected $2.5 billion dairy‑alternative market by 2030. Moreover, the startup aims to export its proteins to the European Union, where regulatory pathways for novel foods are becoming clearer and consumer appetite for sustainable protein is strong.
Funding Landscape and Future Outlook
The EIC’s investment is part of a broader trend of public and private capital flowing into agri‑tech ventures that promise environmental benefits. In the past year, the EU has allocated over €200 million to precision‑fermentation projects, while Gulf sovereign wealth funds have increased their exposure to food‑tech startups. Vivici’s success may encourage more cross‑border collaborations, linking European research expertise with the UAE’s entrepreneurial ecosystem.
Looking ahead, the company will need to navigate regulatory approvals for novel food ingredients in both the Gulf and Europe. Early engagement with food‑safety authorities, coupled with transparent labeling, will be critical to gaining consumer trust. Additionally, scaling production while maintaining cost competitiveness will determine whether fermented proteins can rival traditional dairy on price.
What to watch: As Vivici moves from pilot to commercial scale, investors will monitor its ability to secure long‑term off‑take agreements with major food brands. The startup’s progress could also influence policy decisions in the UAE’s Food‑Tech Innovation Strategy, potentially unlocking further incentives for biotech firms. If the company meets its milestones, it could set a benchmark for how precision fermentation can be integrated into the region’s food supply chain, delivering both economic and environmental dividends.
